Title for MeetingAbstracts
Alphabetical listing of titles
Efficacy and safety of combined therapy with zidovudine (AZT), alpha-interferon (IFNA) and alpha-1-thymosin (TA1) in HIV-infected people.
Efficacy and Safety of DB 289, a New Oral Drug for Treatment of Pneumocystis carinii Pneumonia (PCP) in AIDS Patients.
Efficacy and safety of didanosine (ddI) and tenofovir (TDF) combination as NRTI backbone of highly active antiretroviral treatment (HAART). (24 wk preliminary results from Recover Study).
Efficacy and safety of didanosine (ddI) vs. zidovudine (ZDV) in patients (Pt) with HIV infection no longer benefiting from ZDV therapy. ddI Iberian Study Group.
Efficacy and safety of efavirenz (EFV), lamivudine (3TC), didanosine-EC (DDI-EC), as a once daily regimen for treatment-naive HIV patients: 48 week results from the DART I trial.
Efficacy and Safety of Emtricitabine (FTC) Triple Combination Therapy in HIV-1 Infected Treatment-Naive Male and Female Patients.
Efficacy and safety of enfuvirtide in 23 HIV-infected multiexperienced patients.
Efficacy and safety of half dose compared to full dose Stavudine (d4T) and Zidovudine (AZT) in combination with Didanosine (ddI) in Thai HIV-infected patients: 96 weeks results of ACTT002/ARV065 study.
Efficacy and Safety of HMG-CoA Reductase Inhibitors (Statins) for the Treatment of Protease Inhibitor (PI)-Related Hyperlipidemia: a Retrospective Analysis.
Efficacy and safety of hormone therapy in women with hot flashes.
Efficacy and safety of Indinavir (IDV) 800 mg bid versus 400 mg bid combined with ritonavir (RTV) 100 mg bid in naive patients.
Efficacy and safety of Indinavir/Ritonavir 400/100 mg BID in antiretroviral therapy-naive Thai AIDS patients: a 48-week result.
EFFICACY AND SAFETY OF INDINAVIR/RITONAVIR 400/100 mg BID IN NAIVE HIV-1 INFECTED PATIENTS WITH CD4 <200/mm3: 24-WEEK RESULT.
Efficacy and safety of indinavir/ritonavir combination in the era of pharmacological monitoring.
Efficacy and safety of intermittent oral fumagillin for the treatment of Enterocytozoon bieneusi infections in patients with AIDS (ANRS 054).
EFFICACY AND SAFETY OF KETOCONAZOLE IN HIV INFECTED INFANTS WITH mucocutaneous candidiasis.
Efficacy and safety of lipid-lowering agents in HIV-infected patients on HAART.
Efficacy and Safety of Liposomal Nystatin against Disseminated Candidiasis in Persistently Neutropenic Rabbits.
Efficacy and safety of MDL 28,574A in HIV-positive patients with baseline CD4 values of 100 - 300.
Efficacy and safety of MDL 28,574A in HIV-positive patients with baseline CD4 values of 301-500.
Efficacy and Safety of Moxifloxacin (MXF) vs Cephalexin (with or without Metronidazole) in the Treatment of Mild to Moderate Uncomplicated Skin and Skin Structure Infections (uSSSI).
Efficacy and Safety of Moxifloxacin Vs. Clarithromycin for the Treatment of Community-Acquired Pneumonia.
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Efficacy and safety of nevirapine (NVP) in clinical practice-Australian special access program.
Efficacy and safety of Nevirapine based HAART in a cohort of Thai children.
Efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus (CMV) disease in liver transplant recipients.
Efficacy and safety of passive hyperimmune therapy (PHT) in HIV disease: results of a 12-month study. California Physician Study Group for PHT.
Efficacy and safety of passive hyperimmune therapy PMT in HIV disease: an interim analysis. California Physician Study Group for PHT.
Efficacy and Safety of Peginterferon Alfa-2a (40 KD) Treatment of Patients with HIV/HCV: Results of a Multicenter Trial.
Efficacy and Safety of Pharmacokinetically Enhanced Amoxicillin/Clavulanate (AMX/CA) 2000/125 mg bid for 5 Days vs AMX/CA 875/125 mg bid for 7 Days in the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB).